EEF1A2: A Drug Target / Disease Biomarker (G1917)

Target Name: EEF1A2

NCBI ID: G1917

EEF1A2

EEF1A2: A Drug Target / Disease Biomarker

EEF1A2 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the immune response and has been identified as a potential drug target in the treatment of various diseases.

The immune system is a critical component of the body that protects it against infection and disease. The immune system is made up of a variety of different types of cells and molecules that work together to detect and respond to foreign substances in the body. EEF1A2 is one of these molecules that plays a crucial role in the immune response.

EEF1A2 is a transmembrane protein that is expressed in various tissues throughout the body. It is involved in the regulation of T cell development and function. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. EEF1A2 helps to ensure that T cells are properly developed and that they function properly.

In addition to its role in T cell development and function, EEF1A2 has also been shown to have a variety of other functions in the immune system. For example, it has been shown to help regulate the production of antibodies, which are proteins that are produced by the immune system in response to the presence of a foreign substance in the body. It has also been shown to help coordinate the immune response by ensuring that T cells are properly activated and that they are able to reach their target cells.

As a potential drug target, EEF1A2 has been identified as a target for a variety of different drugs. These drugs are designed to interact with EEF1A2 and disrupt its function in order to treat various diseases. For example, some drugs are being developed to treat cancer by inhibiting the activity of EEF1A2. Others are being developed to treat autoimmune diseases by reducing the activity of EEF1A2.

In addition to its potential as a drug target, EEF1A2 is also of interest as a biomarker. By measuring the level of EEF1A2 in different tissues and fluids, researchers can gain insights into the immune response and the overall health of the body. This can be useful for the development of new diagnostic tests and for the treatment of immune-related diseases.

Overall, EEF1A2 is a protein that plays a critical role in the immune system and has a variety of different functions in the body. As a potential drug target and biomarker, it is of interest for the development of new treatments for various diseases. Further research is needed to fully understand the role of EEF1A2 in the immune system and to develop effective treatments based on its properties.

Protein Name: Eukaryotic Translation Elongation Factor 1 Alpha 2

Functions: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis

The "EEF1A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets